ALT elevation (combined ALT flare and minor relapse groups) showed an elevated risk of HCC (adjusted HR 1.82, 95%CI 1.19–2.79) compared to the normal group (Supplementary Table 1). The gene discussed is GPT; the disease is hepatocellular carcinoma.